Clinical Trial Update: Analgesic Efficacy of Transmucosal Fentanyl for Breakthrough Pain Caused by Interventional Gastrostomy [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the analgesic efficacy of transmucosal fentanyl for breakthrough pain in patients with gastrostomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breakthrough Pain
• Gastrostomy
• Upper Aerodigestive Tract Neoplasms

Drugs mentioned

• transmucosal fentanyl (fentanyl (transmucosal))

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Gastrostomy, Breakthrough Pain | Phase 4 | Status: COMPLETED